Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study

Cefiderocol is a novel siderophore cephalosporin, which has proven in vitro activity against carbapenem-resistant (CR) Gram-negative pathogens and stability towards all carbapenemases. The aim of this study was to describe the first cases of prescriptions and the efficacy of cefiderocol for compassi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bleibtreu, Alexandre, Dortet, Laurent, Bonnin, Remy A., Wyplosz, Benjamin, Sacleux, Sophie-Caroline, Mihaila, Liliana, Dupont, Hervé, Junot, Helga, Bunel, Vincent, Grall, Nathalie, Razazi, Keyvan, Duran, Clara, Tattevin, Pierre, Dinh, Aurélien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911443/
https://www.ncbi.nlm.nih.gov/pubmed/33573148
http://dx.doi.org/10.3390/microorganisms9020282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911443/
https://www.ncbi.nlm.nih.gov/pubmed/33573148
http://dx.doi.org/10.3390/microorganisms9020282

Ejemplares similares